mRNA Process Development and Manufacturing Summit

Start Date : September 20, 2022
End Date : September 22, 2022
Time : 9:00 am to5:00 pm

Phone : +1 617 455 4188
Email : info@hansonwade.com

Location :
Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States

Website

Get Direction View Large Map

Description

Accelerating mRNA Drug Substance Process Scale Up and Manufacturing

Built with biopharmaceutical industry insights, this in-person conference will bring together key opinion leaders to delve deep into the key remaining challenges associated with mRNA process scale up and manufacturing towards regulatory harmonization by optimizing in vitro transcription, purification and analytical validation mRNA drug substance.

With 20+ pioneering speakers from large pharma, innovative biotech and KOLs of academia who are ready to discuss how the future mRNA process development and manufacturing is shaping in accordance with regulatory expectations and emerging tools and technologies to support the development of scalable and commercially viable mRNA-based therapeutics and vaccines, join us in Boston to hear how they address the major challenges facing the industry.

Brochure: https://go.evvnt.com/1170386-3?pid=3506

Speakers: Andreas Kuhn, SVP - RNA Biochemistry and Manufacturing, BioNTech SE, Dipendra Gyawali, Senior Scientist - Analytical Development, Moderna, Dushyant Varshney, CTO, Arcturus Therapeutics, Elaine Peters, Director - Cell and Gene Therapy Analytical Capabilities, Genentech, Emily English, Senior Director - Quality, Cartesian Therapeutics, Harris Makatsoris, Professor - Sustainable Manufacturing Systems, King's College London, Jin Zhou, Executive Director - Process Development; mRNA and Protein Biologics, Ultragenyx Pharmaceutical, Madelyn Johnstone- Robertson, BioProcess Engineer, Afrigen Biologics, Martin Carvalho, Head - Quality, mRNA Centre of Excellence, Sanofi, Nili Schutz, COO, Art Bioscience, Petro Terblanche, Managing Director, Afrigen Biologics, Philippe Alexandre, Gilbert Senior Program Officer - CMC, Bill and Melinda Gates Foundation, Rachit Jain, Director - Process Development, Tessera Therapeutics, Serena Smith, Director - Strategy and Market Intelligence, ThermoFisher Scientific, Srinivasulu Bandi, Director - BioProcess Development, Senda Biosciences, Shefal Parikh, Director - mRNA Process Development, Beam Therapeutics, Steve Pascolo, Professor, University Hospital of Zürich, Xinyue Zhang, Investigator - mRNA Process and Analytical Development, GeneLeap Biotech, Kristie Bloom, Researcher, University of the Witwatersrand, Thomas Aune, Professor, Vanderbilt University Medical Center, Zheng Meng, Senior Director - Analytical Development, Ultragenyx Pharmaceutical, Anna Senczuk, Director - Process Development and mRNA CMC, Seqirus, Ruchi Shah, Associate Director, Eli Lilly and Company

Registration Info

Register Now

Admission :

Drug Developer - Conference + 2 Workshops: USD 4097.00,

Drug Developer - Conference + 1 Workshop: USD 3498.00,

Drug Developer - Conference Only: USD 2899.00,

Academic - Conference + 2 Workshops: USD 3497.00,

Academic - Conference + 1 Workshop: USD 2998.00,

Academic - Conference Only: USD 2499.00,

Service Provider - Conference + 2 Workshops: USD 4897.00,

Service Provider - Conference + 1 Workshop: USD 4198.00,

Service Provider - Conference Only: USD 3499.00

Contact the Organizer

Organized by

Organized by LoveEvvnt1

Hanson Wade

Tel: +1 617 455 4188
Email: info@hansonwade.com


Event Categories: Health & Nutrition.




Your Review

You must be logged in to post a comment.